to-BBB is a Dutch biotechnology company in the field of enhanced drug delivery across the blood-brain
barrier. The company is developing novel treatments for brain disorders by combining existing drugs with
its proprietary brain drug delivery platform. The company’s vision is that the treatment of currently
unserved brain diseases will be best achieved by safely enhancing the blood-to-brain delivery of drugs.
to-BBB is headquartered in The Netherlands at the Leiden Bio Science Park and has established a fully
owned subsidiary, to-BBB Taiwan Ltd., in Taipei, Taiwan.

Web: www.tobbb.com